What is the recovery time after stem cell therapy for Parkinson's Disease?
Recovery depends on whether the protocol uses an infusion or intracerebral surgery. Surgical recovery and graft assessment follow the study schedule; patients should not alter dopaminergic medication without their treating neurologist.
What the evidence shows for Parkinson's Disease
Cell-replacement programmes remain specialised clinical research and must establish identity, purity, dose, surgical delivery, tumour risk, graft survival and clinically meaningful function. Laboratory generation of dopamine-producing neurons supports a research hypothesis, not a commercial efficacy claim. The NINDS stem-cell research overview describes this work, while the FDA patient page states that regenerative medicine therapies are not approved in the United States for Parkinson's disease.
Am I a candidate? → · Parkinson's Disease: full overview → · Parkinson's Disease cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Parkinson's Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Parkinson's Disease cost? (2026)
- Parkinson's Disease stem cell therapy — your questions answered (2026)
- Parkinson's Disease: cell-therapy evidence by therapy class
- MSC vs exosomes for Parkinson's Disease: what the registries show